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Abstracts / Osteoarthritis and Cartilage 21 (2013) S9–S62 S27Results: Expression of DIO2 in articular cartilage was signiﬁcantly
affected by the rs225014 risk allele and joint type (P¼ 3.6 * 10-3 and P¼
4.2 * 10-2, respectively) Furthermore, we observed a single CpG dinu-
cleotide 2 kB upstream of the DIO2 promoter that displayed a signiﬁcant
positive correlation with expression of DIO2 (P ¼ 3.3 * 10-3). In addi-
tion, this CpG dinucleotide appeared signiﬁcantly hypermethylated in
OA cartilage, compared to matched preserved cartilage (P ¼ 1.6 * 10-4)
(Figure 1). Subsequent stratiﬁcation for rs225014 genotypes revealed an
enhanced relation between methylation and expression in carriers of
the rs225014 risk allele. Further stratiﬁcation for joint type did not
reveal any major differences. ChIP on multiple chondrocyte cell lines
identiﬁed a CTCF binding site directly on the location of the identiﬁed
CpG.
Conclusions: Compelling regulatory properties of a single CpG dinu-
cleotide 2 kB upstream of the DIO2 promoter seem responsible for the
observed up regulation of DIO2 expression in OA cartilage, independent
of rs225014 genotypes. However, expression of DIO2 is additionally
modulated by rs225014 genotypes. As a result expression of DIO2 in risk
allele carriers is more sensitive to changes in methylation, indicating an
additive effect, which in turn could be causal to OA susceptibility.
Figure 1. Overview of interrogated CpG dinucleotides in the DIO2 locus. The sixth CpG
dinucleotide from region D associates signiﬁcantly with DIO2 expression (P ¼ 0.0033)
and is differentially methylated between preserved and OA cartilage (P ¼ 1.6 * 10-4).
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GENETIC RISK FACTORS FOR KNEE OA DISPLAY GOOD PREDICTIVE
POWER IN A HIGH RISK GROUP OF OVERWEIGHT AND OBESE
FEMALES
J.B. van Meurs, J. Runhaar, M. Verbiest, S. Bierma-Zeinstra. Erasmus MC,
Rotterdam, Netherlands
Purpose: Over the last few years, several genetic markers have been
identiﬁed to be robustly associated with knee osteoarthritis (OA). These
genetic markers have been identiﬁed by gathering all cases and controls
available. In general, small effect sizes of these risk factors were found,
making OA genetic risk prediction difﬁcult. However, it is known that
the association of the genetic marker with the phenotype can be
context speciﬁc. It could be that in persons with or without major
environmental risk factors, different sets of genes are important. We
therefore set out to test predictive value of DNA variants previously
identiﬁed as being associated to knee OA, in a high risk group of over-
weight and obese, middle-aged women.
Methods:
Study Sample: This study was performed within the PRevention of knee
Osteoarthritis in Overweight Females (PROOF) study. A total of 407
women met the inclusion criteria (BMI  27, no clinical knee OA (ACR
criteria), no contraindications to MRI, no rheumatic diseases), were
invited for baseline measurements. Pre-speciﬁed primary outcome was
incidence of knee OA, deﬁned by incidence of either K&L 2, joint space
narrowing of  1.0 mm or incident clinical knee OA (ACR criteria). After
2.5 years of follow-up, forty-three women (11%) were lost to follow-up
and for a further 72 women no DNA was available.
DNA-variants: We studied DNA variants that have been reported as
being associated with knee OA at genome-wide signiﬁcance level
(P<5x10-8) in women. These included variants in or near: GDF5
(rs143383), GNL3 (rs11177) and DUS4L (also referred to as the Chr 7
locus, rs4730250) and MCF2L (rs11842874). The assay for the MCF2L
variant failed due to technical problems. We subsequently computed
a genetic risk score for the 3 variants that were genotyped successfully,
where the number of carried risk alleles where added per person.
Association between the genetic markers, the genetic risk score andincident knee OAwas tested bymultivariate logistic regression analysis,
adjusting for age and BMI.
Results: In total 92 (31%) women developed OA during the 2.5 year
follow-up time. When the risk for the separate DNA variants were
tested, for all three variants we found increased risk for incident knee
OA with the previously identiﬁed risk allele (OR(95% CI): GDF5: 1.30
(0.91-1.85); GNL3: 1.23(0.86-1.78); Chr7: 1.75(1.10-2.77)). All these risks
were at least twice as large as compared to those previously reported in
large meta-analysis. However, only the odds ratio for the chr 7 locus
reached nominally signiﬁcance (p¼0.018). The genetic risk score, which
was composed of the three SNPs under study, was signiﬁcantly asso-
ciated with incident knee OA (p¼0.007). With each additional risk
allele, the women had 38% more chance for incident knee OA. Whenwe
stratiﬁed the women into 3 groups according to their genetic risk score,
we observed that womenwith 4 or 5 genetic risk alleles had almost 3.5
times higher risk for incident knee OA compared to women that had
0 or 1 risk allele (OR 3.45 (95%CI 1.41-8.47), p¼0.007).
Conclusions: The previously identiﬁed genetic risk markers for knee
OA, were signiﬁcantly associated with incident knee OA in this high risk
group of overweight and obese women. The effect sizes of the studies
DNA variants were larger than those reported previously. These results
indicate that genetic prediction of OA can be dependent on the presence
of other strong clinical risk factors38
THE MTDNA HAPLOGROUPS INFLUENCE THE PROGRESSION OF
OSTEOARTHRITIS (OA). DATA FROM THE OSTEOARTHRITIS
INITIATIVE (OAI)
I. Rego-Pérez y, A. Soto-Hermida y, M. Fernández-Moreno y, J.
Fernández-Tajes y, M.E. Vázquez-Mosquera y, E. Cortés-Pereira y, S.
Relaño-Fernández y, N. Oreiro-Villar y, C. Fernández-López y, F.J.
Blanco y,z. y INIBIC-Hosp. A Coruña. Rheumatology Div. Genomic Group, A
Coruña, Spain; z Proteo-Red/ISCIII, Madrid, Spain
Purpose: The Osteoarthritis Initiative (OAI) is a multicentre study
focused on identifying and evaluating risk factors of knee osteoarthritis
(OA). Previous studies carried out by our group showed the role of the
mitochondrial DNA (mtDNA) haplogroups on the prevalence and
progression of OA. The aim of this study is to replicate our previous
ﬁndings about the inﬂuence of the mtDNA haplogroups on OA
progression in the well characterized cohort of the OAI.
Methods: Data for these analyses are from the OAI public use data
set(s), and assigned the mtDNA haplogroups in 891 Caucasian samples
of the progression subcohort.
We analyzed the inﬂuence of mtDNA haplogroups on OA progression
attending to KL grade, joint space narrow (JSN), presence of osteophytes
and subchondral sclerosis in media tibial compartment, between
baseline and visit 6 (48 months). The progression criteria for KL grade
consisted in an increase of at least one (KL or OARSI) grade to any visit
and any knee; for JSN we considered progression if an increase in score
by a grade above or equal to 0.5 of the OARSI scale to any visit and any
knee occurred. Additionally we also analyzed the inﬂuence of these
mitochondrial polymorphisms on quantitative measurements of carti-
lage morphology from magnetic resonance imaging (MRI) scans: mean
cartilage thickness and volume of cartilage in medial tibia. Appropriate
statistical analyses adjusting by gender, age and body mass index (BMI)
at baseline were carried out using SPSS software (v.19).
Results: Carriers of the mtDNA haplogroup T are at lower risk for KL
grade progression (27.1 % progressors) than carriers of the most
common mtDNA haplogroup H (46.9% progressors) (OR¼0.442;
CI¼0.233-0.835; p¼0.012). As expected, carriers of the haplogroup T are
also better progressors, attending to osteophytes (35.2% progressors)
and subchondral sclerosis (30.2% progressors) in tibia medial
compartment, than carriers of the haplogroup H (53.4% progressors and
45.8% progressors respectively) (OR¼0.481; CI¼0.258-0.897; p ¼ 0.021
and OR¼0.525; CI¼0.275-1.004; p ¼ 0.05 respectively). Regarding to
JSN, carriers of the haplogroup T also showed a better progression
(23.3% progressors) than carriers of the haplogroup H (36.9% pro-
gressors) (OR¼0.510; CI¼0.261-0.995; p ¼ 0.048).
The analyses of quantitative measurements of cartilage morphology
revealed that carriers of the haplogroup T showed a higher mean
cartilage thickness in medial tibia (1.88 mm  0.28) than carriers of the
haplogroup H (1.74 mm 0.27) (borderline p¼ 0.077), as well as higher
